Pharma
Optibrium releases powerful metabolism prediction capability in next generation StarDrop software
Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, launches the latest version of its drug discovery platform, StarDrop 7.5, introducing a powerful module for drug metabolism prediction. ...
Ion channel drug developer Maxion Therapeutics appoints Eva-Lotta Allan as Chair of its Board of Directors
Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announced the appointment of senior industry leader Eva-Lotta Allan as the Chair of its Board of Directors. The announcement comes ...
Lunch & Learn: Early Phase Clinical Trials in Australia - Fast-Tracking Your Development Program
Join us for a Lunch and Learn session to discuss the early phase clinical trial landscape and capabilities in Australia, how this could help accelerate your clinical development program, and benefits of including this region in your trial design. ***This is a free event and open to a...
Building a Solid Foundation: A Guide to Establishing a Data Protection Program at Your Life Sciences Startup
Join us for this webinar in collaboration with MyData Trust! ***This webinar is free and open to all!*** ...
SPT Labtech Empowers UK Genomics Community by Opening its Doors for the firefly® Roadshow
Cambridge, UK, 19 September 2023 – SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, will host the UK leg of the firefly® roadshow at the Company’s headquarters in Melbourn, Cambridgeshire on 26-28 Sept...
Takeda and Sanofi join Milner Therapeutics Consortium
The Milner Therapeutics Institute are excited to announce that two new pharma partners — Takeda and Sanofi — have joined the Milner Consortium in the past month. ...
Inflation Reduction Act: Adjustments to medication pricing and reimbursement
This is part two of a three-part series published in Managed Healthcare Executive. ...
Inflation Reduction Act: Increasing healthcare coverage, reducing healthcare prices. How will it impact manufacturers?
This is part 1 of a three-part series published in Managed Healthcare Executive. ...
An international comparative analysis and roadmap to sustainable biosimilar markets
This study was originally published in Frontiers in Pharmacology.